2nd World Congress on Clinical Trials in Diabetes, Berlin 2017

It is clear that there is a continuing necessity to streamline these issues into a process that will improve drug development in terms of approval and commercialization, and address the various aspects of drug and device development and the way to enhance them.

Once again, our world renowned faculty will tackle issues head, on through a comprehensive program which will focus on key areas including: Design the Best Study Improve Regulatory Process

USD 1.300,00
Industry starts from: USD 1300

Physician/Practicing Medical Professional/ Academic starts from: USD 650

Developing Countries starts from: USD 575.

Speakers: Itamar Raz, Philip Home, Oilver Schnell, Ralph DeFronzo, Stefano del Prato, Roy Eldor, Markolf Hanefeld, Hiddo Lambers Heerspink, John Lachin, James Nolan, Andreas Pfützner, Paolo Pozzilli, Eberhard Standl, Giuseppe M.C. Rosano & many more.